Order

Size
Price
Stock
Qty

Pirfenidone

 - AMR-69
Axon 2647
Based on 967 publications in PubMed
CAS:  53179-13-8
Purity:  100%
  • Soluble in DMSO
  • MF:  C12H11NO
  • MW:  185.22

Description

Orally available agent with therapeutic potential for idiopathic pulmonary fibrosis (IPF; IC50 value 14.44 mM for inhibition of cell proliferation against MRC-5 cells) that has combined anti-inflammatory, antioxidant and antifibrotic effects in experimental models of pulmonary fibrosis. Mechanistically, Pirfenidone inhibits not only TGF-β-induced Smad3, p38 and Akt phosphorylation in human lung fibroblasts (HLFs), but also significantly increased RGS2 mRNA and protein expression in fibroblasts.

Related Products

AXON ID NAME FROM PRICE
1275 SCH 79797 dihydrochloride

From $143.00

1763 CoPo 22

From $132.00

2070 Sulfasalazine

From $49.50

2169 VX 661

From $88.00

2236 IN 1130

From $104.50

2295 PPQ 102

From $110.00

2364 GW 311616A

From $132.00

2367 AM 095 (parent compound)

From $143.00

2501 Pexidartinib

From $66.00

2503 VX 770

From $137.50

2554 LY 2784544

From $104.50

2572 GlyH 101

From $115.50

2576 Eact

From $93.50

2753 CCG 232601

From $176.00

2868 Roquinimex

From $137.50

3307 Pidotimod

From $55.00

Loading...